Questions discussed in this category
For your recommended medication, are you doing a scheduled set dose, or is it primarily symptom-driven?
Is there an absolute cutoff for AST/ALT that you use where the risks outweigh the potential harm reduction benefits of using the medication? &nbs...
If so, you have a recommended tapering strategy?
In what patient populations would you consider using disulfiram (Antabuse) instead of, or in addition to, acamprosate or naltrexone? In your experienc...
Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.
24271272092616725087235002493526247257462378523267
Papers discussed in this category
Journal of addiction medicine, 2021 May-Jun 01
The American journal on addictions, 2023 Mar 20
Journal of addiction medicine, 2020 May/Jun
Alcohol (Fayetteville, N.Y.), 2014-06
American journal of preventive medicine, 2015-10
JHEP reports : innovation in hepatology, 2024 Apr 10